Global Chronic Spontaneous Urticaria Industry

Global Chronic Spontaneous Urticaria Industry Research & Trends Analysis Report

Global Chronic Spontaneous Urticaria Industry

Global Chronic Spontaneous Urticaria Industry Research & Trends Analysis Report


Analysis of the Chronic Spontaneous Urticaria Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Market IntelliX Research, the global market for Chronic Spontaneous Urticaria should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Chronic Spontaneous Urticaria market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Chronic Spontaneous Urticaria market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Antihistamine segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Children has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.

The global key manufacturers of Chronic Spontaneous Urticaria include Mylan N. V., Sanofi, GlaxoSmithKline, Bayer, Merck, Aurobindo Pharma, Hikma Pharmaceuticals, WOCKHARDT and AbbVie, Inc., etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Chronic Spontaneous Urticaria. Report Highlights:

(1) Global Chronic Spontaneous Urticaria market size (value),history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Chronic Spontaneous Urticaria market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Chronic Spontaneous Urticaria market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Chronic Spontaneous Urticaria segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Chronic Spontaneous Urticaria segment by type and by application and regional segment by type and by application.

(6) Chronic Spontaneous Urticaria industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Antihistamine

Monoclonal Antibody

Other

Market segment by application, can be divided into

Children

Adult

Market segment by players, this report covers

Mylan N. V.

Sanofi

GlaxoSmithKline

Bayer

Merck

Aurobindo Pharma

Hikma Pharmaceuticals

WOCKHARDT

AbbVie, Inc.

Cipla Inc.

F. Hoffmann La Roche Ltd.

Teva Pharmaceutical Industries, Ltd.

Pfizer, Inc.

Novartis AG

Eli Lilly and Company

Allergan

Lupin

1 Market Overview

1.1 Product Overview and Scope of Chronic Spontaneous Urticaria

1.2 Global Chronic Spontaneous Urticaria Market Size and Forecast

1.3 China Chronic Spontaneous Urticaria Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Chronic Spontaneous Urticaria Share in Global Market, 2019-2030

1.4.2 Chronic Spontaneous Urticaria Market Size: China VS Global, 2019-2030

1.5 Chronic Spontaneous Urticaria Market Dynamics

1.5.1 Chronic Spontaneous Urticaria Market Drivers

1.5.2 Chronic Spontaneous Urticaria Market Restraints

1.5.3 Chronic Spontaneous Urticaria Industry Trends

1.5.4 Chronic Spontaneous Urticaria Industry Policy

2 Global Competitive Situation by Company

2.1 Global Chronic Spontaneous Urticaria Revenue by Company (2019-2024)

2.2 Global Chronic Spontaneous Urticaria Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Chronic Spontaneous Urticaria Concentration Ratio

2.4 Global Chronic Spontaneous Urticaria Mergers & Acquisitions, Expansion Plans

2.5 Global Chronic Spontaneous Urticaria Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Chronic Spontaneous Urticaria Revenue by Company (2019-2024)

3.2 China Chronic Spontaneous Urticaria Chronic Spontaneous Urticaria Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Chronic Spontaneous Urticaria, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Chronic Spontaneous Urticaria Industry Chain

4.2 Chronic Spontaneous Urticaria Upstream Analysis

4.3 Chronic Spontaneous Urticaria Midstream Analysis

4.4 Chronic Spontaneous Urticaria Downstream Analysis

5 Sights by Type

5.1 Chronic Spontaneous Urticaria Classification

5.1.1 Antihistamine

5.1.2 Monoclonal Antibody

5.1.3 Other

5.2 By Type, Global Chronic Spontaneous Urticaria Market Size & CAGR, 2019 VS 2024 VS 2030

5.3 By Type, Global Chronic Spontaneous Urticaria Revenue, 2019-2030

6 Sights by Application

6.1 Chronic Spontaneous Urticaria Segment by Application

6.1.1 Children

6.1.2 Adult

6.2 By Application, Global Chronic Spontaneous Urticaria Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Application, Global Chronic Spontaneous Urticaria Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Chronic Spontaneous Urticaria Market Size, 2019 VS 2024 VS 2030

7.2 By Region, Global Chronic Spontaneous Urticaria Market Size, 2019-2030

7.3 North America

7.3.1 North America Chronic Spontaneous Urticaria Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Chronic Spontaneous Urticaria Market Size Market Share

7.4 Europe

7.4.1 Europe Chronic Spontaneous Urticaria Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Chronic Spontaneous Urticaria Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Chronic Spontaneous Urticaria Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Chronic Spontaneous Urticaria Market Size Market Share

7.6 South America

7.6.1 South America Chronic Spontaneous Urticaria Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Chronic Spontaneous Urticaria Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Chronic Spontaneous Urticaria Market Size & CAGR，2019 VS 2024 VS 2030

8.2 By Country, Global Chronic Spontaneous Urticaria Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Chronic Spontaneous Urticaria Market Size, 2019-2030

8.3.2 By Company, U.S. Chronic Spontaneous Urticaria Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.3.4 By Application, U.S. Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.4 Europe

8.4.1 Europe Chronic Spontaneous Urticaria Market Size, 2019-2030

8.4.2 By Company, Europe Chronic Spontaneous Urticaria Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.4.4 By Application, Europe Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.5 China

8.5.1 China Chronic Spontaneous Urticaria Market Size, 2019-2030

8.5.2 By Company, China Chronic Spontaneous Urticaria Revenue Market Share, 2019-2024

8.5.3 By Type, China Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.5.4 By Application, China Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.6 Japan

8.6.1 Japan Chronic Spontaneous Urticaria Market Size, 2019-2030

8.6.2 By Company, Japan Chronic Spontaneous Urticaria Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.6.4 By Application, Japan Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.7 South Korea

8.7.1 South Korea Chronic Spontaneous Urticaria Market Size, 2019-2030

8.7.2 By Company, South Korea Chronic Spontaneous Urticaria Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.7.4 By Application, South Korea Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Chronic Spontaneous Urticaria Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Chronic Spontaneous Urticaria Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.8.4 By Application, Southeast Asia Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.9 India

8.9.1 India Chronic Spontaneous Urticaria Market Size, 2019-2030

8.9.2 By Company, India Chronic Spontaneous Urticaria Revenue Market Share, 2019-2024

8.9.3 By Type, India Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.9.4 By Application, India Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Chronic Spontaneous Urticaria Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Chronic Spontaneous Urticaria Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

8.10.4 By Application, Middle East & Asia Chronic Spontaneous Urticaria Revenue Market Share, 2023 VS 2030

9 Global Manufacturers Profile

9.1 Mylan N. V.

9.1.1 Mylan N. V. Company Information, Head Office, Market Area and Industry Position

9.1.2 Mylan N. V. Company Profile and Main Business

9.1.3 Mylan N. V. Chronic Spontaneous Urticaria Models, Specifications and Application

9.1.4 Mylan N. V. Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.1.5 Mylan N. V. Recent Developments

9.2 Sanofi

9.2.1 Sanofi Company Information, Head Office, Market Area and Industry Position

9.2.2 Sanofi Company Profile and Main Business

9.2.3 Sanofi Chronic Spontaneous Urticaria Models, Specifications and Application

9.2.4 Sanofi Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.2.5 Sanofi Recent Developments

9.3 GlaxoSmithKline

9.3.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position

9.3.2 GlaxoSmithKline Company Profile and Main Business

9.3.3 GlaxoSmithKline Chronic Spontaneous Urticaria Models, Specifications and Application

9.3.4 GlaxoSmithKline Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.3.5 GlaxoSmithKline Recent Developments

9.4 Bayer

9.4.1 Bayer Company Information, Head Office, Market Area and Industry Position

9.4.2 Bayer Company Profile and Main Business

9.4.3 Bayer Chronic Spontaneous Urticaria Models, Specifications and Application

9.4.4 Bayer Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.4.5 Bayer Recent Developments

9.5 Merck

9.5.1 Merck Company Information, Head Office, Market Area and Industry Position

9.5.2 Merck Company Profile and Main Business

9.5.3 Merck Chronic Spontaneous Urticaria Models, Specifications and Application

9.5.4 Merck Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.5.5 Merck Recent Developments

9.6 Aurobindo Pharma

9.6.1 Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position

9.6.2 Aurobindo Pharma Company Profile and Main Business

9.6.3 Aurobindo Pharma Chronic Spontaneous Urticaria Models, Specifications and Application

9.6.4 Aurobindo Pharma Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.6.5 Aurobindo Pharma Recent Developments

9.7 Hikma Pharmaceuticals

9.7.1 Hikma Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

9.7.2 Hikma Pharmaceuticals Company Profile and Main Business

9.7.3 Hikma Pharmaceuticals Chronic Spontaneous Urticaria Models, Specifications and Application

9.7.4 Hikma Pharmaceuticals Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.7.5 Hikma Pharmaceuticals Recent Developments

9.8 WOCKHARDT

9.8.1 WOCKHARDT Company Information, Head Office, Market Area and Industry Position

9.8.2 WOCKHARDT Company Profile and Main Business

9.8.3 WOCKHARDT Chronic Spontaneous Urticaria Models, Specifications and Application

9.8.4 WOCKHARDT Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.8.5 WOCKHARDT Recent Developments

9.9 AbbVie, Inc.

9.9.1 AbbVie, Inc. Company Information, Head Office, Market Area and Industry Position

9.9.2 AbbVie, Inc. Company Profile and Main Business

9.9.3 AbbVie, Inc. Chronic Spontaneous Urticaria Models, Specifications and Application

9.9.4 AbbVie, Inc. Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.9.5 AbbVie, Inc. Recent Developments

9.10 Cipla Inc.

9.10.1 Cipla Inc. Company Information, Head Office, Market Area and Industry Position

9.10.2 Cipla Inc. Company Profile and Main Business

9.10.3 Cipla Inc. Chronic Spontaneous Urticaria Models, Specifications and Application

9.10.4 Cipla Inc. Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.10.5 Cipla Inc. Recent Developments

9.11 F. Hoffmann La Roche Ltd.

9.11.1 F. Hoffmann La Roche Ltd. Company Information, Head Office, Market Area and Industry Position

9.11.2 F. Hoffmann La Roche Ltd. Company Profile and Main Business

9.11.3 F. Hoffmann La Roche Ltd. Chronic Spontaneous Urticaria Models, Specifications and Application

9.11.4 F. Hoffmann La Roche Ltd. Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.11.5 F. Hoffmann La Roche Ltd. Recent Developments

9.12 Teva Pharmaceutical Industries, Ltd.

9.12.1 Teva Pharmaceutical Industries, Ltd. Company Information, Head Office, Market Area and Industry Position

9.12.2 Teva Pharmaceutical Industries, Ltd. Company Profile and Main Business

9.12.3 Teva Pharmaceutical Industries, Ltd. Chronic Spontaneous Urticaria Models, Specifications and Application

9.12.4 Teva Pharmaceutical Industries, Ltd. Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.12.5 Teva Pharmaceutical Industries, Ltd. Recent Developments

9.13 Pfizer, Inc.

9.13.1 Pfizer, Inc. Company Information, Head Office, Market Area and Industry Position

9.13.2 Pfizer, Inc. Company Profile and Main Business

9.13.3 Pfizer, Inc. Chronic Spontaneous Urticaria Models, Specifications and Application

9.13.4 Pfizer, Inc. Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.13.5 Pfizer, Inc. Recent Developments

9.14 Novartis AG

9.14.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

9.14.2 Novartis AG Company Profile and Main Business

9.14.3 Novartis AG Chronic Spontaneous Urticaria Models, Specifications and Application

9.14.4 Novartis AG Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.14.5 Novartis AG Recent Developments

9.15 Eli Lilly and Company

9.15.1 Eli Lilly and Company Company Information, Head Office, Market Area and Industry Position

9.15.2 Eli Lilly and Company Company Profile and Main Business

9.15.3 Eli Lilly and Company Chronic Spontaneous Urticaria Models, Specifications and Application

9.15.4 Eli Lilly and Company Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.15.5 Eli Lilly and Company Recent Developments

9.16 Allergan

9.16.1 Allergan Company Information, Head Office, Market Area and Industry Position

9.16.2 Allergan Company Profile and Main Business

9.16.3 Allergan Chronic Spontaneous Urticaria Models, Specifications and Application

9.16.4 Allergan Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.16.5 Allergan Recent Developments

9.17 Lupin

9.17.1 Lupin Company Information, Head Office, Market Area and Industry Position

9.17.2 Lupin Company Profile and Main Business

9.17.3 Lupin Chronic Spontaneous Urticaria Models, Specifications and Application

9.17.4 Lupin Chronic Spontaneous Urticaria Revenue and Gross Margin, 2019-2024

9.17.5 Lupin Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Chronic Spontaneous Urticaria Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
How are players chosen for the research coverage of the Chronic Spontaneous Urticaria Market study?
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
What is the expected rate of growth in the Chronic Spontaneous Urticaria Market?
From 2025 to 2030, the Chronic Spontaneous Urticaria Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
What does the future hold for the Chronic Spontaneous Urticaria Market?
As the shift to value addition continues, companies in the Chronic Spontaneous Urticaria Market face the dual challenge of improving interoperability to optimize performance and experience.
What is the estimated global market value of the Chronic Spontaneous Urticaria Market?
The Chronic Spontaneous Urticaria Market is expected to reach a considerable market valuation.